welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Abstracts & Posters
P4.1 Puberty is delayed or absent in Duchenne Muscular Dystrophy boys on chronic glucocorticoid therapy
source: Neuromuscular Disorders
year: 2011
authors: M.M. Rutter, S.R. Rose, J. Collins, H. Sucherew, B.L. Wong, I. Rybalsky
summary/abstract:Chronic glucocorticoids (GCs) are standard therapy and slow disease progression in Duchenne Muscular Dystrophy (DMD). However, GCs cause adverse endocrine effects, including pubertal delay, growth failure and osteoporosis. Absent/delayed puberty is an important problem in DMD which, in turn, negatively impacts bone health, growth, self esteem and muscle strength. The prevalence in DMD is unknown, and it is frequently under-recognized and untreated.
The objective is to determine the prevalence of absent /delayed puberty in DMD boys on GC therapy.
organization: Cincinnati Children’s Hospital Medical Center, USADOI: 10.1016/j.nmd.2011.06.966
read more
rareRelated
-
The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal SuppressionDuchenne muscular dystrophy (DMD or Duch...
-
CoQ10 and Prednisone in Non-Ambulatory DMDThis study will help determine if CoQ10 ...
-
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophyObjective: To assess safety and efficac...
-
PTC Therapeutics Announces Publication of Data Demonstrating the Clinical Differentiated Benefit of DeflazacortPTC Therapeutics, Inc. today announced t...
-
Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History w...We describe changes in pulmonary functio...
-
Potential Mechanisms for Prolonged Loss of Ambulation with Deflazacort in Duchenne Muscular Dystrophy – Tolera...Objective: To summarize prolonged loss ...
-
Delayed Puberty in Duchenne Muscular Dystrophy: For ParentsThis information sheet is about delayed ...